Every day, children of all ages undergo painful procedures and radiologic imaging in hospitals across the nation. Procedural sedation (PS) is often needed to alleviate the pain, anxiety, and distress associated with these procedures and to facilitate the safe completion of the procedure itself. Appropriate analgesia/ sedation for procedures is critical to a child's emotional well-being as well as to obtain better outcomes. Weisman et al 1 reported that inadequate analgesia for initial procedures in young children may diminish the effectiveness of adequate analgesia in subsequent procedures.
There is wide variability in the provision of PS and analgesia at different institutions, and this variability is due in part to the availability of sedation providers.
Anesthesiologists have been unable to meet the growing demands of PS, and nonanesthesiologists are increasingly providing PS for children. 2 Several studies have demonstrated the safety of procedural sedation using ketamine and nitrous oxide (N 2 O) by emergency physicians and intensivists. [3] [4] [5] [6] [7] Pediatric intensivists and emergency physicians have been the primary nonanesthesiologist sedation providers because they have the greatest experience managing the pediatric airway in patients in the emergency department (ED) and ICU. However, pediatric hospitalists (PH) are increasingly providing sedation for various painful procedures and for radiologic imaging of children across the nation. It is important to establish that PH can provide safe and effective PS even though many of them lack the training in airway management provided during fellowship training of emergency physicians and intensivists.
The hospitalist sedation program at St Louis Children's Hospital (SLCH) consists of 50 PH who provide procedural sedation at multiple settings in the hospital, including the ED, Ambulatory Procedure Center (APC), and Pediatric Acute Wound Service (PAWS). A variety of sedation agents are used by PH based on their training and sedation credentialing. A tiered system of sedation providers exists, ranging from PH who provide sedation only in the ED (tier 1) to providers who are trained to use propofol in the APC (tier 3). 8 The sedation service follows safety standards established by the American Academy of Pediatrics and the Ameri can Society of Anesthesiologists, as well as institutional standards. [9] [10] [11] Adverse events during sedation are tracked by using a quality improvement (QI) sedation database in which all sedation-related adverse events are manually entered.
We previously analyzed the complication rates of propofol sedations performed by PH at SLCH, and we found that the propofol sedation program was effective, with low rates of major complications (0.18%). 12 However, sedation with propofol is provided by the more experienced tier 3 PH who have had specialized training in the operating room to manage the pediatric airway. The primary sedation agents used by all PH sedation providers (tiers 1, 2, and 3) are ketamine and N 2 O. To determine the effectiveness and safety of PS performed by all PH at SLCH, we measured rates of complications that occurred during sedations performed by PH at SLCH using ketamine and N 2 O. These rates were determined from a retrospective review and analysis of a QI database. To the best of our knowledge, there are no previous studies reporting the safety of procedural sedation performed by PH using keta mine and N 2 O.
METHODS

Study Design
Since 2007, sedation providers at SLCH have completed a QI form at the end of each procedure. The QI form collects information on patient age range (patient gender is not recorded), hospital setting where the sedation is performed, nature of the procedure, patient risk factors or active medical problems, sedation plan, agents used, and complications. The data are entered into a QI database by an administrative assis tant. The database was analyzed for all the sedations performed by PH using ketamine and N 2 O from February 2007 to February 2013.
The QI form was revised and expanded in September 2011 to gather more specifi c information about each episode of sedation. The expanded form included additional data elements about the procedures performed, concentration of N 2 O used for sedation, and an expanded complication section including queries for emergency anesthesia consul tation and occurrence of rash, hives, stridor, laryngospasm, and seizures. Elements that are present only in the new QI form are noted in Table 1 , and percentages of these elements are calculated by using the number of sedations performed using N 2 O and ketamine since September 2011. Thus, rates for major complications include "emergency anesthesia consultation" only since 2011. The new QI form also has queries for the concentration of N 2 O used. The QI form only queries for inadequate sedation resulting in a procedure not being completed. The percentage of patients with procedures completed successfully is thus derived by subtracting those with procedures not completed due to inadequate sedation from the total number of patients sedated. There is no query in the QI data form regarding patient distress during a procedure.
Sedation Protocol
Presedation assessment is completed by the sedation provider before all sedations. Patients are monitored according to guidelines of the American Academy of Pediatrics and American So ciety of Anesthesiologists.
9,11 Children being sedated for painful procedures are ge nerally premedicated with 0.2 to 0.3 mg/kg of oxycodone (maximum dose: 10 mg) and 15 mg/kg of acetaminophen (maximum dose: 650 mg). N 2 O is administered via a face mask at a concentration of 70% for ∼5 minutes and then N 2 O is decreased to 50% for a total duration of ∼15 minutes. After sedation, 100% oxygen is administered for 2 minutes
www.hospitalpediatrics.org to prevent diffusion hypoxia as well as to improve the scavenging of exhaled N 2 O. Ketamine is generally administered at an initial dose of 0.5 to 1 mg/kg. Additional doses are administered at a dose of 0.5 to 1 mg/kg. Vital signs and depth of sedation according to the University of Michigan sedation scale 13 are monitored continuously and recorded every 5 minutes in the chart. The QI form records inadequate sedation and sedation level not achieved or exceeded. Pain scores are recorded in the sedation forms by using the Face, Legs, Activity, Cry, Consolability scale or the Wong-Baker Faces Pain Rating Scale based on the age of the patient. 14, 15 Only scores >6 are recorded in the QI form.
Statistical Analysis
P values for the comparison of charac teristics and proportions of complications between patients sedated by using ketamine or N 2 O were calculated by using Pearson's χ 2 test for large cell counts and Fisher's exact test for cell counts ≤5. Confi dence intervals for proportions of complications were calculated by using exact methods when the number of complications was small (≤5) and according to Woolf's method when the number of complications was larger.
Institutional review board approval was obtained for the study. The age range of patients sedated, procedure for which patients were sedated, and the hospital setting for the sedation are presented in Table 2 .
RESULTS
PH
Children aged between 7 months and 4 years were sedated more frequently with ketamine, whereas children >4 
DISCUSSION
The sedation program at SLCH evidenced >99% successful sedations, with low rates of major complications when performing sedation using ketamine or N 2 O (0.04% and 0.06%, respectively). Indeed, among the major
www.hospitalpediatrics.org complications, only 4 unplanned ad mi ssions (2 for each agent) were recorded in the QI database for 8870 sedations performed over a 6-year time period. The QI database did not have queries for emergency anesthesiologist consultation until September 2011, and there were none recorded since then. Previous studies reported similar low major complication rates when using propofol for sedation. 12 The overall rate of respiratory events was 2.15% for ketamine sedations. This fi nding is comparable to the incidence of respiratory adverse events (3.9%) reported in a meta-analysis by Green et al 3 of 8282 pediatric ketamine sedations performed in 32 EDs. Respiratory events were defi ned in the study by Green et al as any of the following: upper airway obstruction, apnea, oxygen desaturation to ≤90%, or laryngospasm. The QI database at SLCH did not have queries for apnea and laryngospasm until September 2011. There were no episodes of apnea, stridor, or laryngospasm recorded since September 2011 during ketamine or N 2 O sedations.
For N 2 O sedations, the rate of respiratory events was 0.91%. In a prospective study, Zier et al 5 reported an incidence of 0.1% for respiratory events with N 2 O sedations. However, that study used a dental nasal mask, which likely entrained room air and diluted the concentration of N 2 O that was administered to patients. 5 At SLCH, a full face mask was used for N 2 O sedations, which minimized entrainment of room air. Furthermore, 99% of N 2 O sedations used 70% N 2 O, and 73% of the children were premedicated with a sedative or opioid, likely resulting in a deeper level of sedation compared with the study results of Zier et al.
Among the airway interventions occurring with ketamine and N 2 O sedations (3.76% and 1.10%, respectively) (Table 1) , the vast majority (89%) were airway repositioning. This is not considered an adverse event but rather an expected intervention necessary to relieve airway obstruction commonly noted during deep sedation of children. As expected, the rate of airway repositioning was some threefold higher with ketamine compared with N 2 O, consistent with the generally deeper level of sedation obtained with ketamine.
The rate of major complications ob served in the 8870 ketamine and N 2 O sedations performed by PH at SLCH was 0.05%. This rate is comparable to that observed by Coulores et al 16 in their study of the impact of provider specialty on the major complication rates. Their analysis included 133 941 procedural sedation records submitted to the Pediatric Sedation Research Consortium by 38 participating institutions. Major complications were defi ned as aspiration, death, cardiac arrest, unplanned hospital admissions, or emergency anesthesia consultation. Rates of major complication during sedation by pediatricians in their group were 0.12% (95% confi dence interval: 0.07-0.2) in 12 113 sedations. They did not report the agents used by the pediatricians in their study.
The current study did have limitations, primarily involving the accuracy of the data. The QI database at SLCH relies on a voluntary reporting system, and some providers do not fi ll out forms at the end of each sedation. Providers may also not report transient desaturations or obstruction that are self-resolving and of no clinical signifi cance. Errors in entering the information both onto the form and into the database also occur; manual entry into the database is performed by an administrative assistant rather than the sedation provider. For instance, among the 8870 sedations, 12 were recorded as occurring at hospital locations at which PH do not administer sedation. Likewise, 13 procedures were recorded for which PH at SLCH do not provide sedation. It is likely that there are errors/omissions resulting in both underestimation and overestimation of various complication rates. The QI form does not include queries regarding the state of the patient (eg, if the patient was in pain or was crying during the procedure). Thus, it is possible that the procedure was completed, but the patient might not have been adequately sedated. Finally, the study refl ects the sedation experience of 1 hospitalist group at a single institution.
CONCLUSIONS
The current study documents that PH at SLCH provide safe and effective sedation using ketamine and N 2 O. This fi nding is important because there are barriers in many institutions for PH to provide deep sedation. These barriers result in procedures (eg, incision and drainage of abscesses) being performed in the operating room by anesthesiologists, which not only raises costs signifi cantly but also exposes patients to the unnecessary risks of general anesthesia. There have been many studies illustrating the safe use of ketamine and N 2 O for procedural sedation by ED physicians and intensivists. [3] [4] [5] [6] [7] This is the fi rst study demonstrating the safe and effective use of ketamine and N 2 O by PH. It is important to note that a comprehensive sedation training program with anesthesia oversight and close collaboration with anesthesiologists is a key element of the PH sedation program at SLCH. Use of ketamine and N 2 O by PH across the nation, with similar sedation training models in collaboration with anesthesiologists, can help provide safe and effective sedation for a variety of procedures, which will improve the overall care for patients undergoing painful procedures.
